Transparency Market Research published new
market report "Pain Management Therapeutics Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2012 - 2018," in 2011, the global pain management
therapeutics market was valued at USD 40.93 billion and is expected to decline
at a CAGR of (5.5%) from 2012 to 2018, to reach an estimated value of USD 29.47
billion in 2018.
Browse the full report at http://www.transparencymarketresearch.com/pain-management-therapeutics.html
The global pain
management therapeutics market is expected to experience a decline in revenues
at a CAGR of (5.5%) during the forecast period, mainly due to patent
expirations of the leading branded drugs. Although the global incidence rates
of cancer, diabetes and other debilitating diseases that cause various chronic pain
conditions is on a rise, the decline in market revenue is inevitable due to
generic incursion for the top pain management drugs. Moreover, lack of a strong
pipeline of novel or combination drugs that could help restore the positive
growth of the overall market is also expected to contribute to the overall
decline in the global pain management therapeutics market.
Administration of
analgesics is the first line of treatment for the management of acute as well
as chronic pain conditions. Some of the factors driving the growth of this
market include the favorable regulatory and healthcare reforms such as the U.S.
Patient Protection and Affordable Care Act of 2010. Also, the economic and
effective nature of treatment with therapeutics compared to other modes, such
as neurostimulation devices and acupuncture, will continue to fuel the uptake
of drugs in pain management.
The market for
non-steroidal anti-inflammatory drugs (NSAIDs) accounted for the largest share
by revenue in 2011, of the total pain management therapeutics market by
therapeutic class. This class comprises of some of the oldest known painkillers
such as diclofenac, ibuprofen and Aspirin (acetylsalicylic acid) which are now
commonly available as over-the-counter (OTC) medications, globally. However,
the patent expiry of Celebrex (celecoxib) in 2013 is expected to negatively
impact the market with a decline in revenues post patent expiry.
The class of
other non-narcotic analgesics consists of acetaminophen, sold as OTC drugs in
the names of Tylenol, Panadol and Excedrin, and is expected to record the
highest CAGR of 3.1% during the forecast period. Increase in the uptake of OTC
drugs across the globe to overcome common pain conditions such as headache and
body ache, will be responsible for this growth. The loss of patent exclusivity
of other key brands such as Cymbalta (duloxetine), OxyContin (oxycodone) and
Lidoderm (lidocaine) scheduled in the year 2013 will have a profound impact on
the growth of the overall market.
North America was
the largest regional market by revenue in 2011, due to the presence of one or
more branded drugs belonging to each therapeutic class. However, the region is
expected to record the lowest CAGR due to the looming patent expiries of these
brands.
The market for
generic formulations accounted for a larger share of the overall pain
management therapeutics market in 2011, as against branded formulations. The
market for branded pharmaceuticals was highly fragmented in 2011, with Pfizer,
Inc., Purdue Pharma LP and Eli Lilly & Co. contributing to over 80% of the
total market revenue. Other important players in this market include Endo
Health Solutions, AstraZeneca PLC, Johnson
& Johnson, and Merck & Co., Inc.
The pain
management therapeutics market is segmented as follows:
Pain Management Therapeutics
Market, by Therapeutic Class
·
Anticonvulsants
·
Antidepressants
·
Anesthetics
·
NSAIDs
·
Opioids
·
Other
Non-Narcotic Analgesics (Acetaminophen)
·
Anti-Migraine
Agents
Pain Management Therapeutics
Market, by Indication
·
Neuropathic
Pain
·
Fibromyalgia
·
Arthritic
Pain, by Type
o Osteoarthritis
o Rheumatoid Arthritis
·
Chronic
Back Pain
·
Migraine
·
Post-operative
Pain
·
Cancer
Pain
Pain Management Therapeutics
Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
About Us:
Transparency
Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers.
We
are privileged with highly experienced team of Analysts, Researchers and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a
competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
0 comments:
Post a Comment